Synthesis and Electrocatalytic Activity of [FeFe]-Hydrogenase Model Complexes with Non-Innocent Chelating Nitrogen-Donor Ligands

Synthetic [FeFe] Hydrogenase Active Site Model Complexes

The binding assessment with human serum albumin of novel six-coordinate Pt(IV) complexes, containing bidentate nitrogen donor/methyl ligands

The interactions between platinum complexes and human serum albumin (HSA) play crucial roles in the distribution, metabolism, and activity of platinum-based anticancer drugs. Octahedral platinum (IV) complexes represent a significant class of anticancer agents that display molecular pharmacological properties different from cisplatin. In this study, the interaction between two Pt(IV) complexes ...

Synthesis and characterization of some transition metal complexes with new mixed-donor schiff base ligands derived from 2-hydroxynaphthaldehyde

2-[3-(2-Formylnaphthoxy)-2-hydroxypropoxy] naphthaldehyde (1) have been prepared by reaction of 2-hydroxynaphthaldehyde with 1,3-dichloro-2-propanol. New N2O3 macro-acyclic ligands (L1, L2) synthesized from the reaction of (1) with aniline or cyclohexylamine. Ni (II), Co (II) and Cu (II) complexes was prepared from reaction of Schiff-bases with metal chloride and nitrate salts. All of these com...

Synthesis, crystallographic, spectroscopic studies and biological activity of new cobalt(II) complexes with bioactive mixed sulindac and nitrogen-donor ligands

Four novel complexes [Co(H2O)4(sul)2] 1, [Co(2-ampy)2(sul)2] 2, [Co(H2O)2(1,10-phen) (sul)2] 3 and [Co(2,9-dimephen)(sul)2] 4 (sul = sulindac, 2-ampy = 2-amino pyridine, 1,10-phen = 1,10-phenanthroline and 2,9-dimeph = 2,9-dimethyl-1,10-phenanthroline) were prepared and characterized by IR, UV-Visible spectroscopy and magnetic properties. The crystal structures of complexes 1 and 4 were determi...

Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.

Three new ruthenium complexes with bidentate chloroquine analogue ligands, [Ru(η(6)-cym)(L(1))Cl]Cl (1, cym = p-cymene, L(1) = N-(2-((pyridin-2-yl)methylamino)ethyl)-7-chloroquinolin-4-amine), [Ru(η(6)-cym)(L(2))Cl]Cl (2, L(2) = N-(2-((1-methyl-1H-imidazol-2-yl)methylamino)ethyl)-7-chloroquinolin-4-amine) and [Ru(η(6)-cym)(L(3))Cl] (3, L(3) = N-(2-((2-hydroxyphenyl)methylimino)ethyl)-7-chloroqu...